Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing of total RNA from spinal cord total lysates of the PS19 tauopathy mouse model.

ABSTRACT: RNA seqeuncing was perfomed to compare transcriptomic profiles of PS19 and control mice at four and nine months.

ORGANISM(S): Mus musculus

PROVIDER: GSE186228 | GEO | 2021/10/23

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA sequencing from hippocampal total lysates of the rTg4510 tauopathy mouse model.

Project description:RNA seqeuncing was perfomed to compare transcriptomic profiles of rTg4510 and control at three, six and nine month time points.

2021-10-21 | GSE186140 | GEO

RNA sequencing of total RNA from spinal cord total lysates of the PS19 tauopathy mouse model.

Project description:RNA sequencing of total RNA from spinal cord total lysates of the PS19 tauopathy mouse model.

| PRJNA773047 | ENA

PS19 and PS19/C3aR KO RNAseq data

Project description:Hippocampal tissue from 9 month old WT, C3aR KO, PS19 and PS19/C3aR KO mice was processed

2018-11-08 | GSE114910 | GEO

Seed-competent tau monomer initiates pathology in PS19 tauopathy mice

Project description:Tau Monomer from age controlled healthy and Alzheimer's Disease LUM2_C10053 LUM2_C10054 LUM2_C10055 LUM2_C10056 LUM2_C10057 LUM2_C10058 Tau fibril from Alzheimer's Disease LUM2_630897 Tau monomer from brain of PS19 mouse at age week 1, 2, 3, 4, 5, 6 LUM1_C11496 to LUM1_C11501 Tau monomer from brain of PS19 mouse at age 1 year LUM1_705666

2022-01-06 | MSV000088651 | MassIVE

Gene Expression of PS19 Tau transgenic mice

Project description:Expression of PS19 Tau Transgenic mice from hippocampus at different ages 3, 6, 9, and 12 months We used Affy arrays to understand the global expression profile of PS19 Tau transgenic mice

2018-08-28 | GSE89979 | GEO

PS19 brain lysate transfection changing ER stress gene expression in Biosensor cell

Project description:To investigate whether PS19 brain lysate transfection changes ER stress gene expression in Biosensor cell

2022-12-22 | GSE217525 | GEO

Inpp5d haplodeficiency alleviates tau pathology in the PS19 mouse model of Tauopathy.

Project description:IntroductionA noncoding variant (rs35349669) within INPP5D, a lipid and protein phosphatase restricted to microglia in the brain, is linked to increased susceptibility to Alzheimer's disease (AD). While Inpp5d is well-studied in amyloid pathology, its role in tau pathology remains unclear.MethodsPS19 Tauopathy mice were crossed with Inpp5d-haplodeficient (Inpp5d+/-) mice to examine the impact of Inpp5d in tau pathology.ResultsIncreased INPP5D expression correlated positively with phospho-Tau AT8 in PS19 mice. Inpp5d haplodeficiency mitigated hyperphosphorylated tau levels (AT8, AT180, AT100, and PHF1) and motor deficits in PS19 mice. Transcriptomic analysis revealed an up-regulation of genes associated with immune response and cell migration.DiscussionOur findings define an association between INPP5D expression and tau pathology in PS19 mice. Alleviation in hyperphosphorylated tau, motor deficits, and transcriptomics changes in haplodeficient-Inpp5d PS19 mice indicate that modulation in INPP5D expression may provide therapeutic potential for mitigating tau pathology and improving motor deficits.HighlightsThe impact of Inpp5d in the context of tau pathology was studied in the PS19 mouse model. INPP5D expression is associated with tau pathology. Reduced Inpp5d expression in PS19 mice improved motor functions and decreased total and phospho-Tau levels. Inpp5d haplodeficiency in PS19 mice modulates gene expression patterns linked to immune response and cell migration. These data suggest that inhibition of Inpp5d may be a therapeutic approach in tauopathies.

| S-EPMC11247686 | biostudies-literature

Transcriptome analysis of spinal cord microglia and total spinal cord

Project description:Transcriptome analysis of spinal cord microglia and total spinal cord from Lewis rats intratracheally treated with PBS, neomycin or vancomycin.

2021-12-21 | GSE192411 | GEO

Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys.

Project description:Tauopathy, characterized by the hyperphosphorylation and accumulation of the microtubule-associated protein tau, and the accumulation of Aβ oligomers, constitute the major pathological hallmarks of Alzheimer's disease. However, the relationship and causal roles of these two pathological changes in neurodegeneration remain to be defined, even though they occur together or independently in several neurodegenerative diseases associated with cognitive and movement impairment. While it is widely accepted that Aβ accumulation leads to tauopathy in the late stages of the disease, it is still unknown whether tauopathy influences the formation of toxic Aβ oligomers. To address this, we generated transgenic cynomolgus monkey models expressing Tau (P301L) through lentiviral infection of monkey embryos. These monkeys developed age-dependent neurodegeneration and motor dysfunction. Additionally, we performed a stereotaxic injection of adult monkey and mouse brains to express Tau (P301L) via AAV9 infection. Importantly, we found that tauopathy resulting from embryonic transgenic Tau expression or stereotaxic brain injection of AAV-Tau selectively promoted the generation of Aβ oligomers in the monkey spinal cord. These Aβ oligomers were recognized by several antibodies to Aβ1-42 and contributed to neurodegeneration. However, the generation of Aβ oligomers was not observed in other brain regions of Tau transgenic monkeys or in the brains of mice injected with AAV9-Tau (P301L), suggesting that the generation of Aβ oligomers is species- and brain region-dependent. Our findings demonstrate for the first time that tauopathy can trigger Aβ pathology in the primate spinal cord and provide new insight into the pathogenesis and treatment of tauopathy.

| S-EPMC10514290 | biostudies-literature

Transcriptome analysis of spinal cord microglia and total spinal cord

Project description:Transcriptome analysis of spinal cord microglia and total spinal cord

| PRJNA791374 | ENA